NOTCH1与STAT3互为ceRNA调控口腔鳞癌肿瘤干细胞的机制研究

基本信息
批准号:81702709
项目类别:青年科学基金项目
资助金额:19.00
负责人:赵志立
学科分类:
依托单位:中南大学
批准年份:2017
结题年份:2020
起止时间:2018-01-01 - 2020-12-31
项目状态: 已结题
项目参与者:黄生高,龚朝建,阳燕,陈林,贺智晶,朱飞亚,鲜红春,雷婧诗,孙彬灿
关键词:
STAT3通路肿瘤干细胞NOTCH1通路口腔鳞癌竞争性内源RNA
结项摘要

CeRNA(competing endogenous RNA) is a kind of endogenous RNAs that regulate their targets in a miRNA competing based mechanism through hare multiple MicroRNA response elements. In this project ,we hypothesize that NOTCH1 and STAT3 may have the potential interaction serve as ceRNA, which regulate cancer stem cells of OSCC by competing a panel of shared miRNAs. This project including 3 parts:Firstly,we screen the shared miRNA by bioinformatic analysis and data mining.Then the expression pattern of NOTCH1 and STAT3 as well as their shared miRNA in human OSCC cell line, C57BL/6 mice model and human samples were detected and biological validation were performed using functional NOTCH1 and STAT3 3'UTR transfection and DICER knock down assay to confirm the ceRNA interaction of NOTCH1 and STAT3. Secondly,we explore the molecular mechanism of NOTCH1 and STAT3 shared miRNA’s influence on cancer stem cells and chemotherapeutic resistence.Knockdown or overpression of shared miRNA were performed in OSCC cell lines and mice model. Thirdly, we will further design combined exogenous competing miRNA sponges based on our data, exploring experimental therapeutics of OSCC by inhibiting NOTCH1 and STAT3 shared miRNA in vitro and in vivo, even clinical trials if possible,investigating their role in oral cancer carcinogenesis and treatment. Achievments of this project will better understand the multiple layer interpretation of key tumor suppressor gene in cancer stem cells of OSCC and develop new stratege for OSCC therapeutics.

CeRNA(competing endogenous RNA) 是能够通过miRNA应答元件竞争结合相同miRNA进而调控靶基因的内源性RNA。通过前期研究,我们提出如下假说:“口腔鳞癌中NOTCH1和STAT3互为ceRNA,通过竞争共享miRNA调控对方的表达,进而调控肿瘤干细胞的功能,影响口腔鳞癌患者的生存及预后”。本项目拟从以下方面开展工作:1.利用生物信息学分析及口腔鳞癌细胞系、小鼠模型和人类标本分析和验证NOTCH1 及STAT3 共享miRNA,并通过转染彼此 3'UTR 及敲减DICER 策略验证NOTCH1 及STAT3 的ceRNA关系;2.明确共享miRNA对口腔癌肿瘤干细胞的调控机制及其对口腔癌化疗耐受的影响;3.设计外源竞争性miRNA海绵,探索体外及小鼠舌癌模型的实验性治疗。研究结果将加深对口腔癌肿瘤干细胞分子网络调控机制的理解,为口腔癌的治疗提供新的靶点及策略

项目摘要

项目成果
{{index+1}}

{{i.achievement_title}}

{{i.achievement_title}}

DOI:{{i.doi}}
发表时间:{{i.publish_year}}

暂无此项成果

数据更新时间:2023-05-31

其他相关文献

1

Loss of a Centrosomal Protein,Centlein, Promotes Cell Cycle Progression

Loss of a Centrosomal Protein,Centlein, Promotes Cell Cycle Progression

DOI:10.16476/j.pibb.2019.0092
发表时间:2019
2

PI3K-AKT-mTOR通路对骨肉瘤细胞顺铂耐药性的影响及其机制

PI3K-AKT-mTOR通路对骨肉瘤细胞顺铂耐药性的影响及其机制

DOI:
发表时间:2021
3

TGF-β1-Smad2/3信号转导通路在百草枯中毒致肺纤维化中的作用

TGF-β1-Smad2/3信号转导通路在百草枯中毒致肺纤维化中的作用

DOI:10.13692/ j.cnki.gywsy z yb.2016.03.002
发表时间:2016
4

Complete loss of RNA editing from the plastid genome and most highly expressed mitochondrial genes of Welwitschia mirabilis

Complete loss of RNA editing from the plastid genome and most highly expressed mitochondrial genes of Welwitschia mirabilis

DOI:https://doi.org/10.1007/s11427-018-9450-1
发表时间:2019
5

Wnt 信号通路在非小细胞肺癌中的研究进展

Wnt 信号通路在非小细胞肺癌中的研究进展

DOI:
发表时间:2016

赵志立的其他基金

批准号:61702240
批准年份:2017
资助金额:20.00
项目类别:青年科学基金项目

相似国自然基金

1

PTEN与TGFBR1互为ceRNA调控口腔鳞癌自噬的分子机制

批准号:81472528
批准年份:2014
负责人:孙志军
学科分类:H1805
资助金额:85.00
项目类别:面上项目
2

TAZ/TEAD4-SOX2调控轴参与口腔鳞癌肿瘤干细胞干性维持的机制研究

批准号:81602378
批准年份:2016
负责人:李中武
学科分类:H1810
资助金额:17.00
项目类别:青年科学基金项目
3

肿瘤抑制因子PAG1调控口腔鳞癌的分子机制研究

批准号:81902783
批准年份:2019
负责人:丛蓓蓓
学科分类:H1803
资助金额:21.00
项目类别:青年科学基金项目
4

Exosome介导的lincRNA-HOTAIR和PTEN互为ceRNA调控喉癌凋亡与自噬的机制研究

批准号:81572647
批准年份:2015
负责人:刘鸣
学科分类:H1803
资助金额:42.00
项目类别:面上项目